Austria

Efferon secures €2.5M to expand Blood Purification Technology for Sepsis Treatment
Villach-based biotech company Efferon has secured €2.5 million in seed funding to scale production of its blood purification technology designed for the treatment of sepsis and septic shock.

The best Articles in our Network